Product Overview
IMOVAX® Rabies Vaccine is a preservative-free, inactivated vaccine prepared using human diploid cell culture (HDCV). It is indicated for both pre-exposure and post-exposure prophylaxis against rabies in individuals of all ages. Each single-dose vial (SDV) contains 2.5 IU/mL of rabies virus antigen, formulated for intramuscular injection.
IMOVAX is produced by Sanofi and meets WHO and CDC guidelines for rabies prevention. It is suitable for individuals at risk of rabies exposure—including travelers, veterinarians, animal handlers—and for those requiring immediate post-exposure protection.
Product Features
- Inactivated rabies vaccine derived from purified human diploid cell culture (HDCV)
- Provides both pre-exposure and post-exposure prophylaxis against rabies
- Preservative-free formulation, suitable for individuals with preservative sensitivities
- Each 1 mL dose contains 2.5 IU of rabies virus antigen for intramuscular administration
- Supplied as a single-dose vial (SDV), convenient for individual treatment or travel clinics
Product Specifications
| Catalog Number/SKU | MF-49281025251 |
| Application | Rabies Vaccine Kit |
| Container type | Single-Dose Vial |
| Dosage Form | Injection |
| Generic Drug Code | 99542 |
| Generic Drug Name | Rabies Vaccine Human Diploid, Preservative Free |
| NDC Number | 49281025251 |
| Storage Requirement | Requires Refrigeration |
| Strength | 2.5 IU / mL |
| Type | Intramuscular |
| UNSPSC Code | 51201617 |
| User | Pediatric to Adult |
| Volume | 1 ml |
